Avadel Pharmaceuticals plc: Director Dealings Disclosed
Why we think this is neutral
This RNS announcement is related to director dealings and does not contain any of the mandatory news types that would require a more detailed analysis. As a result, the sentiment is assessed as neutral.
Key Points
- Director dealings disclosed by Morgan Stanley Europe SE
- Purchases and sales of 0.01 ordinary shares in Avadel Pharmaceuticals plc
Summary
The pharmaceutical company has disclosed director dealings, providing details on purchases and sales of its shares.
Avadel Pharmaceuticals plc has released an RNS announcement regarding director dealings. The disclosure provides information on purchases and sales of the company's 0.01 ordinary shares by Morgan Stanley Europe SE, an exempt principal trader connected to Avadel Pharmaceuticals plc.
DIRECTOR DEALINGS